White Paper

2020 WC Drug Trend Report

The annual Drug Trend Report is released as a comprehensive analysis of the major drivers in the sector of WC retail pharmacy. Delivering the report in 2021 has required us to examine the truly unprecedented circumstances of the last 12 months, and undoubtedly, 2020 was a historic year.

White Paper Summary

In the wake of an unprecedented year for workers’ compensation pharmacy, myMatrixx was able to achieve positive outcomes, according to the newly released 2020 Drug Trend Report. Despite challenges that included the COVID-19 pandemic, an unpredictable environment for new claims and continuing issues such as the opioid misuse crisis, myMatrixx-managed plans saw a 2.6% reduction in cost per days’ supply last year.

myMatrixx releases this report annually as a comprehensive analysis of the major drivers in workers’ compensation retail pharmacy. Looking back at 2020 required in-depth analysis of the many ways COVID-19 affected our sector, from treatment of work-related cases of the disease to the broader economic and statistical impacts. This starting point in turn helped to inform a wider investigation into the trends that shape our industry year-in and year-out. The 2020 Drug Trend Report also examines the state of generic utilization, the growing importance of home delivery and electronic prescribing, and the latest developments in specialty drugs that claims professionals and industry stakeholders need to know.

Register to download the full content

To learn more about myMatrixx, please visit their website.

myMatrixx® is a pharmacy benefit management company dedicated to workers’ compensation and uniquely able to deliver customized solutions and high touch customer service. For more information, visit myMatrixx.com.

More from Risk & Insurance

More from Risk & Insurance